Stéphanie Durand-Panteix

c-Myc and Rel/NF-κB Are the Two Master Transcriptional Systems Activated in the Latency III Program of Epstein-Barr Virus-Immortalized B Cells

Nathalie Faumont, Stéphanie Durand-Panteix, Martin Schlee et al. · Journal of Virology · 2009 · 56 citations · Full text

Immune Regulation, Immunology, Pathology +22

B7-H1, Which Represses EBV-Immortalized B Cell Killing by Autologous T and NK Cells, Is Oppositely Regulated by c-Myc and EBV Latency III Program at Both mRNA and Secretory Lysosome Levels

Stéphanie Durand-Panteix, Mona Farhat, Ibtissam Youlyouz‐Marfak et al. · The Journal of Immunology · 2012 · 36 citations

Adaptive Immune System, Ebv-immortalized B Cells, Immunology +25

²¹²Pb α-Radioimmunotherapy Targeting CD38 in Multiple Myeloma: A Preclinical Study

Isabelle Quelven, Jacques Monteil, Magali Sage et al. · Journal of Nuclear Medicine · 2019 · 34 citations · Full text

Preclinical study of 212Pb alpha-radioimmunotherapy targeting CD20 in non-Hodgkin lymphoma

Stéphanie Durand-Panteix, Jacques Monteil, Magali Sage et al. · British Journal of Cancer · 2021 · 25 citations · Full text

Lymphoid Neoplasia, Medicine, Malignant Blood Disorder +9

RelA and RelB cross-talk and function in Epstein–Barr virus transformed B cells

A. Chanut, Fanny Duguet, Abdelghafour Marfak et al. · Leukemia · 2013 · 16 citations

Relb Cross-talk, Humoral Response, Immunology +9